Novel Strategies for Anti-Tumor Vaccines

  • 37k

    Total downloads

  • 145k

    Total views and downloads

Articles

ORIGINAL RESEARCH

Published on 08 Aug 2019

A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients

  • Michal Bassani-Sternberg
  • Antonia Digklia
  • Florian Huber
  • Dorothea Wagner
  • Christine Sempoux
  • Brian J. Stevenson
  • Anne-Christine Thierry
  • Justine Michaux
  • HuiSong Pak
  • 8 more
  • Lana E. Kandalaft
A Phase Ib Study of the Combination of Personalized Autologous Dendritic Cell Vaccine, Aspirin, and Standard of Care Adjuvant Chemotherapy Followed by Nivolumab for Resected Pancreatic Adenocarcinoma—A Proof of Antigen Discovery Feasibility in Three Patients
doi 10.3389/fimmu.2019.01832
  • 10,166 views
  • 60 citations

Participating Journals

Impact

  • 145kTopic views
  • 104kArticle views
  • 37kArticle downloads
View impact